Oncology Immunotherapy: building the fourth pillar of cancer treatmen... Cancer treatment has been traditionally characterised by surgery, chemotherapy, and radiation.
Oncology Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes ... Researchers also dove into socio-economic disparities in cancer care.
Oncology New horizons in breast cancer care Interview with Markus Kosch, Daiichi Sankyo head of Oncology Business Division in Europe.
Oncology The challenges and opportunities for kidney cancer care reco... Kidney cancer care is rapidly approaching a tipping point in the UK.
Oncology Realising the promise of genomic testing across oncology Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world.
Oncology Diversity by design: the importance of DE&I in oncology tria... “First, do no harm”; is an ethical axiom at the heart of medical research; physicians worldwide pledge to uphold the oath to serve patients.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
